Newbridge Financial Services Group, Inc. Pfizer Inc Transaction History

Newbridge Financial Services Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 11, 2024	BUY	$25.26 - $29.6 $81,412 - $95,400	3,223 Added 21.15%	18,462 $516,000
Q1 2024 Apr 24, 2024	SELL	$25.89 - $29.73 $52,712 - $60,530	-2,036 Reduced 11.79%	15,239 $422,000
Q4 2023 Mar 28, 2024	BUY	$26.13 - $33.94 $72,353 - $93,979	2,769 Added 19.09%	17,275 $497,000
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $81,316 - $95,050	2,534 Added 21.17%	14,506 $481,000
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $20,985 - $24,279	-581 Reduced 4.63%	11,972 $439,000
Q1 2023 Apr 18, 2023	BUY	$39.39 - $51.28 $41,004 - $53,382	1,041 Added 9.04%	12,553 $512,000
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $5,552 - $7,248	-133 Reduced 1.14%	11,512 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $111,150 - $135,686	2,540 Added 27.9%	11,645 $510,000
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $35,176 - $41,708	756 Added 9.05%	9,105 $477,000
Q1 2022 Apr 26, 2022	SELL	$45.75 - $56.69 $137 - $170	-3 Reduced 0.04%	8,349 $432,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $96,978 - $143,753	2,347 Added 39.08%	8,352 $493,000
Q3 2021 Oct 27, 2021	BUY	$39.25 - $50.42 $64,841 - $83,293	1,652 Added 37.95%	6,005 $258,000
Q2 2021 Sep 07, 2021	BUY	$35.91 - $40.68 $1,580 - $1,789	44 Added 1.02%	4,353 $170,000
Q1 2021 Sep 07, 2021	BUY	$33.49 - $37.77 $29,772 - $33,577	889 Added 25.99%	4,309 $156,000
Q4 2020 Sep 07, 2021	BUY	$33.47 - $42.56 $27,512 - $34,984	822 Added 31.64%	3,420 $126,000
Q3 2020 Sep 07, 2021	BUY	$31.75 - $37.25 $82,486 - $96,775	2,598 New	2,598 $95,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.